The mainstay of treatment remains meeting well defined standards of care that have been
shown to influence morbidity and mortality. These include use of systemic steroids, early …

Duchenne muscular dystrophy (DMD) is a genetic, progressive neuromuscular condition
that is marked by the long-term muscle deterioration with significant implications of …

Duchenne muscular dystrophy (DMD) results in a progressive cardiomyopathy that
produces significant morbidity and mortality. To improve the quality of life in patients with …

The life-limiting complications of Duchenne muscular dystrophy (DMD) include loss of lung
function and progressive cardiomyopathy; when patients are treated with assisted …

Duchenne muscular dystrophy (DMD) cardiomyopathy (DCM) is characterized by a
hypokinetic, dilated phenotype progressively increasing with age. Regular cardiac care is …

Introduction Duchenne muscular dystrophy (DMD) is a devastating, progressive
neuromuscular disorder for which there is no cure. As the dystrophin gene is located on the …

Background Heart failure (HF) is a significant cause of mortality in children and therefore
there is interest in understanding the optimal way to support these children with Ventricular …

The dystrophin-glycoprotein complex (DGC), situated at the sarcolemma dynamically
remodels during cardiac disease. This review examines DGC remodeling as a common …

Duchenne's muscular dystrophy is an X-linked neuromuscular disease that manifests as
muscle atrophy and cardiomyopathy in young boys. However, a considerable percentage of …

Abstract Purpose of Review Duchenne muscular dystrophy is one of many neuromuscular
disorders, but it frequently causes severe disability early in life and early death. Cardiac …